VACCINES FOR PREVENTING MENINGOCOCCAL INFECTIONS

Number of patents in Portfolio can not be more than 2000

United States of America Patent

SERIAL NO

15064857

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention stems from the finding that the interaction between the β2 adrenoceptor (β2AP) and type IV pilus-associated proteins initiates a process leading to the opening of the blood-brain barrier. The invention therefore pertains to a vaccine for preventing the spreading of meningococci into the meningeal space, wherein said vaccine allows the production of antibodies inhibiting the interaction between the type IV pilus-associated proteins and the β2AP.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)101 RUE DE TOLBIAC PARIS 75013
UNIVERSITE PARIS DESCARTES12 RUE DE L'ECOLE DE MÉDECINE PARIS 75006

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
COUREUIL, Mathieu Paris, FR 4 2
MARULLO, Stefano Paris, FR 14 51
NASSIF, Xavier Paris, FR 28 69

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation